Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?

David M. Livermore; Jenny M. Andrews; Peter M. Hawkey; Pak-Leung Ho; Yoram Keness; Yohei Doi; David Paterson; Neil Woodford

doi:10.1093/jac/dks088

Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?

David M. Livermore, Jenny M. Andrews, Peter M. Hawkey, Pak-Leung Ho, Yoram Keness, Yohei Doi, David Paterson, Neil Woodford

Research output: Contribution to journal › Article › peer-review

126 Citations (Scopus)

Original language	English
Pages (from-to)	1569-1577
Number of pages	9
Journal	Journal of Antimicrobial Chemotherapy
Volume	67
Issue number	7
DOIs	https://doi.org/10.1093/jac/dks088
Publication status	Published - 2012

Access to Document

10.1093/jac/dks088

Cite this

@article{693c17ecf9f34ea9a8a8a20e283493b5,

title = "Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?",

author = "Livermore, {David M.} and Andrews, {Jenny M.} and Hawkey, {Peter M.} and Pak-Leung Ho and Yoram Keness and Yohei Doi and David Paterson and Neil Woodford",

year = "2012",

doi = "10.1093/jac/dks088",

language = "English",

volume = "67",

pages = "1569--1577",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",